Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amina Zoubeidi

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Endocrinology|January 31, 2023
Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate CancerShaghayegh Nouruzi, Nakisa Tabrizian, Amina Zoubeidi
Recent Patents on Anti-Cancer Drug Discovery|November 5, 2016
Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in CancerSepideh Vahid, Daksh Thaper, Amina Zoubeidi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancerAmina Zoubeidi, Kim Chi, Martin Gleave
Advances in Experimental Medicine and Biology|January 5, 2020
Neural Transcription Factors in Disease ProgressionDaksh Thaper, Sepideh Vahid, Amina Zoubeidi
Nature Reviews. Urology|February 21, 2018
Cellular plasticity and the neuroendocrine phenotype in prostate cancerAlastair H Davies, Himisha Beltran, Amina Zoubeidi
Cancers|April 12, 2014
The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate CancerJennifer L Bishop, Daksh Thaper, Amina Zoubeidi
Molecular and Cellular Endocrinology|March 19, 2017
Patient-derived xenografts: A platform for accelerating translational research in prostate cancerAlastair H Davies, Yuzhuo Wang, Amina Zoubeidi
Endocrine-Related Cancer|December 6, 2019
The epigenetic and transcriptional landscape of neuroendocrine prostate cancerAlastair Davies, Amina Zoubeidi, Luke A Selth
The Urologic Clinics of North America|October 23, 2012
Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptorYohann Loriot, Amina Zoubeidi, Martin E Gleave
Expert Opinion on Investigational Drugs|November 18, 2008
Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancerKim N Chi, Amina Zoubeidi, Martin E Gleave
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Endocrinology|January 31, 2023
Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate CancerShaghayegh Nouruzi, Nakisa Tabrizian, Amina Zoubeidi
Recent Patents on Anti-Cancer Drug Discovery|November 5, 2016
Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in CancerSepideh Vahid, Daksh Thaper, Amina Zoubeidi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancerAmina Zoubeidi, Kim Chi, Martin Gleave
Advances in Experimental Medicine and Biology|January 5, 2020
Neural Transcription Factors in Disease ProgressionDaksh Thaper, Sepideh Vahid, Amina Zoubeidi
Nature Reviews. Urology|February 21, 2018
Cellular plasticity and the neuroendocrine phenotype in prostate cancerAlastair H Davies, Himisha Beltran, Amina Zoubeidi
Cancers|April 12, 2014
The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate CancerJennifer L Bishop, Daksh Thaper, Amina Zoubeidi
Molecular and Cellular Endocrinology|March 19, 2017
Patient-derived xenografts: A platform for accelerating translational research in prostate cancerAlastair H Davies, Yuzhuo Wang, Amina Zoubeidi
Endocrine-Related Cancer|December 6, 2019
The epigenetic and transcriptional landscape of neuroendocrine prostate cancerAlastair Davies, Amina Zoubeidi, Luke A Selth
The Urologic Clinics of North America|October 23, 2012
Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptorYohann Loriot, Amina Zoubeidi, Martin E Gleave
Expert Opinion on Investigational Drugs|November 18, 2008
Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancerKim N Chi, Amina Zoubeidi, Martin E Gleave
Pageof 14